Annual Total Long Term Liabilities
$36.57 M
-$511.00 K-1.38%
31 December 2023
Summary:
Actinium Pharmaceuticals annual total long term liabilities is currently $36.57 million, with the most recent change of -$511.00 thousand (-1.38%) on 31 December 2023. During the last 3 years, it has risen by +$36.57 million (+1218966.67%). ATNM annual total long term liabilities is now -1.38% below its all-time high of $37.08 million, reached on 31 December 2022.ATNM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$36.15 M
-$147.00 K-0.40%
30 September 2024
Summary:
Actinium Pharmaceuticals quarterly total long term liabilities is currently $36.15 million, with the most recent change of -$147.00 thousand (-0.40%) on 30 September 2024. Over the past year, it has dropped by -$421.00 thousand (-1.15%). ATNM quarterly long term liabilities is now -3.18% below its all-time high of $37.34 million, reached on 30 June 2022.ATNM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATNM Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -1.1% |
| 3 y3 years | +10000.0% | +10000.0% |
| 5 y5 years | +5262.5% | +5200.7% |
ATNM Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.4% | >+9999.0% | -3.2% | >+9999.0% |
| 5 y | 5 years | -1.4% | >+9999.0% | -3.2% | >+9999.0% |
| alltime | all time | -1.4% | -3.2% |
Actinium Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $36.15 M(-0.4%) |
| June 2024 | - | $36.30 M(-0.4%) |
| Mar 2024 | - | $36.43 M(-0.4%) |
| Dec 2023 | $36.57 M(-1.4%) | $36.57 M(-0.3%) |
| Sept 2023 | - | $36.69 M(-0.4%) |
| June 2023 | - | $36.82 M(-0.4%) |
| Mar 2023 | - | $36.95 M(-0.3%) |
| Dec 2022 | $37.08 M(>+9900.0%) | $37.08 M(-0.3%) |
| Sept 2022 | - | $37.21 M(-0.3%) |
| June 2022 | - | $37.34 M(>+9900.0%) |
| Mar 2022 | - | $2000.00(-33.3%) |
| Dec 2021 | $3000.00(-99.0%) | $3000.00(-25.0%) |
| Sept 2021 | - | $4000.00(-95.1%) |
| June 2021 | - | $82.00 K(-58.4%) |
| Mar 2021 | - | $197.00 K(-36.7%) |
| Dec 2020 | $311.00 K(-54.4%) | $311.00 K(-26.0%) |
| Sept 2020 | - | $420.00 K(-20.5%) |
| June 2020 | - | $528.00 K(-16.7%) |
| Mar 2020 | - | $634.00 K(-7.0%) |
| Dec 2019 | $682.00 K(+4989.6%) | $682.00 K(-18.9%) |
| Sept 2019 | - | $841.10 K(-10.5%) |
| June 2019 | - | $940.30 K(-9.4%) |
| Mar 2019 | - | $1.04 M(+7641.8%) |
| Dec 2018 | $13.40 K(>+9900.0%) | $13.40 K(>+9900.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2012 | - | $72.90 K(+2.2%) |
| June 2012 | - | $71.30 K(+11.1%) |
| Mar 2012 | - | $64.20 K(>+9900.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2011 | - | $53.80 K(0.0%) |
| June 2011 | - | $53.80 K(-14.3%) |
| Mar 2011 | - | $62.80 K(+7.0%) |
| Dec 2010 | $58.70 K(-14.3%) | $58.70 K(+9.5%) |
| Sept 2010 | - | $53.60 K(-28.9%) |
| June 2010 | - | $75.40 K(+3.3%) |
| Mar 2010 | - | $73.00 K(+6.6%) |
| Dec 2009 | $68.50 K(+37.6%) | $68.50 K(+4.7%) |
| Sept 2009 | - | $65.40 K(+8.6%) |
| June 2009 | - | $60.20 K(+0.2%) |
| Mar 2009 | - | $60.10 K(+20.7%) |
| Dec 2008 | $49.80 K(+38.3%) | $49.80 K(+6.4%) |
| Sept 2008 | - | $46.80 K(+11.4%) |
| June 2008 | - | $42.00 K(+7.7%) |
| Mar 2008 | - | $39.00 K(+8.3%) |
| Dec 2007 | $36.00 K(+148.3%) | $36.00 K(+14.3%) |
| Sept 2007 | - | $31.50 K(+51.4%) |
| June 2007 | - | $20.80 K(+43.4%) |
| Dec 2006 | $14.50 K | $14.50 K |
FAQ
- What is Actinium Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Actinium Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ATNM is $36.57 M
What is the all time high annual total long term liabilities for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual total long term liabilities is $37.08 M
What is Actinium Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ATNM is $36.15 M
What is the all time high quarterly long term liabilities for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly total long term liabilities is $37.34 M
What is Actinium Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ATNM quarterly total long term liabilities has changed by -$421.00 K (-1.15%)